INFLAMMATORY-BOWEL-DISEASE; SELECTIVE CYCLOOXYGENASE-2 INHIBITORS; EXPERIMENTAL COLITIS; TAURINE CHLORAMINE; 5-AMINOSALICYLIC ACID; ACTIVATION; ALPHA; MECHANISM; ROFECOXIB; OXIDATION
DRUG DESIGN DEVELOPMENT AND THERAPY, v.9, pp.4227 - 4237
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.